R. Anliacik

A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset.

G. Gurman, G. Seval, K. Dalva, 2023, Clinical lymphoma, myeloma & leukemia.